Charles Horsburgh
Professor · Boston Univ Sch of Med
Credentials: · ·
History
Present
Infectious Disease
Internal Medicine
Research
Mycobacterium avium complex infection in the acquired immunodeficiency syndrome
Review · New England Journal of Medicine · 1991 · Sole author · 781 citations
Three months of rifapentine and isoniazid for latent tuberculosis infection
New England Journal of Medicine · 2011 · 746 citations
Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin
New England Journal of Medicine · 1993 · Last of 6 authors · 592 citations
42 papers
38 papers
35 papers
- FR
31 papers
22 papers · 7 as a fellow
- RA
17 papers
16 papers
14 papers · 2 as a fellow
Grants
- 2020–2027
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial
National Institute of Allergy and Infectious Diseases · U01
PI · $7.5M · University of California, San Francisco
- 2017–2024
Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $4.6M · Boston University Medical Campus
- 2014–2022
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
National Institute of Allergy and Infectious Diseases · U19
Project lead · $2.9M · Rbhs-New Jersey Medical School
- 2003–2021
BU Clinical HIV/AIDS Research Training Program (BU-CHART)
National Institute of Allergy and Infectious Diseases · T32
Contact PI · $2.9M · Boston Medical Center
Clinical trials
- 2022–2027
Principal investigator · Active not recruiting · Phase 2
Boston University
- 2015–2022
Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB
Principal investigator · Completed · Phase 2
Boston University